Biotechnology Assets (Spain) Market Value
| BST Stock | 0.34 0.01 3.03% |
| Symbol | Biotechnology |
Biotechnology Assets 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotechnology Assets' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotechnology Assets.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Biotechnology Assets on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Biotechnology Assets SA or generate 0.0% return on investment in Biotechnology Assets over 30 days. Biotechnology Assets is related to or competes with Laboratorios Farmaceuticos, Atrys Health, and Oryzon Genomics. More
Biotechnology Assets Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotechnology Assets' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotechnology Assets SA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.8 | |||
| Information Ratio | 0.0207 | |||
| Maximum Drawdown | 49.57 | |||
| Value At Risk | (3.70) | |||
| Potential Upside | 3.57 |
Biotechnology Assets Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotechnology Assets' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotechnology Assets' standard deviation. In reality, there are many statistical measures that can use Biotechnology Assets historical prices to predict the future Biotechnology Assets' volatility.| Risk Adjusted Performance | 0.0395 | |||
| Jensen Alpha | 0.2436 | |||
| Total Risk Alpha | (0.51) | |||
| Sortino Ratio | 0.0238 | |||
| Treynor Ratio | (0.72) |
Biotechnology Assets Backtested Returns
Biotechnology Assets appears to be out of control, given 3 months investment horizon. Biotechnology Assets secures Sharpe Ratio (or Efficiency) of 0.0491, which signifies that the company had a 0.0491% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Biotechnology Assets SA, which you can use to evaluate the volatility of the firm. Please makes use of Biotechnology Assets' Downside Deviation of 4.8, mean deviation of 2.39, and Risk Adjusted Performance of 0.0395 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Biotechnology Assets holds a performance score of 3. The firm shows a Beta (market volatility) of -0.3, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Biotechnology Assets are expected to decrease at a much lower rate. During the bear market, Biotechnology Assets is likely to outperform the market. Please check Biotechnology Assets' downside variance, daily balance of power, and the relationship between the maximum drawdown and skewness , to make a quick decision on whether Biotechnology Assets' price patterns will revert.
Auto-correlation | -0.41 |
Modest reverse predictability
Biotechnology Assets SA has modest reverse predictability. Overlapping area represents the amount of predictability between Biotechnology Assets time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotechnology Assets price movement. The serial correlation of -0.41 indicates that just about 41.0% of current Biotechnology Assets price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.41 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Biotechnology Assets lagged returns against current returns
Autocorrelation, which is Biotechnology Assets stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biotechnology Assets' stock expected returns. We can calculate the autocorrelation of Biotechnology Assets returns to help us make a trade decision. For example, suppose you find that Biotechnology Assets has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biotechnology Assets regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biotechnology Assets stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biotechnology Assets stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biotechnology Assets stock over time.
Current vs Lagged Prices |
| Timeline |
Biotechnology Assets Lagged Returns
When evaluating Biotechnology Assets' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biotechnology Assets stock have on its future price. Biotechnology Assets autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biotechnology Assets autocorrelation shows the relationship between Biotechnology Assets stock current value and its past values and can show if there is a momentum factor associated with investing in Biotechnology Assets SA.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biotechnology Stock
Biotechnology Assets financial ratios help investors to determine whether Biotechnology Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Assets security.